Street Talk

Childbirth medtech eyes US market with $30m raise

Sarah Thompson, Kanika Sood and Emma Rapaport

Jul 28, 2025 – 3.46pm

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Already a subscriber?

VitalTrace, a homegrown medtech that’s designed a device to monitor maternal and fetal wellbeing during childbirth, has launched a Series B capital raising to put it on the pathway to commercialisation.

The West Australian start-up, founded by doctor Arjun Kaushik in 2016, is targeting local and international institutional investors for $30 million, tapping Acova Capital to launch a non-deal roadshow and capital raising.

Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones.

Kanika Sood is a journalist based in Sydney who writes for the Street Talk column.

Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review.